Skip to main content

High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria



Previous studies have indicated a high risk of hepatocellular carcinoma in acute hepatic porphyrias. In this retrospective study we present the incidence of primary liver cancer and clinical characteristics in a cohort of 179 acute porphyria patients above the age of 50 years.


Twenty-three cases with primary liver cancer were found either by a surveillance program or due to clinical suspicion. Standardized rate ratio was used to estimate the relative risk of primary liver cancer after indirect standardization. Survival data were calculated using the Kaplan-Meier method.


The mean age at diagnosis was 69 years. Hepatocellular carcinoma was found in 19 patients while four patients had cholangiocarcinoma or a combination of the two. Four patients had underlying cirrhosis. Mean tumour size was 4.3 cm in the surveillance group and 10.3 cm in the non-surveillance group (p = 0.01). The overall relative risk of primary liver cancer was 86 above the age of 50: 150 for women and 37 for men. Mean survival time was 5.7 years.


Acute hepatic porphyria carries a high risk of primary liver cancer above the age of 50 which warrants ultrasound surveillance. Sex distribution and frequency of cirrhosis differs from more common aetiologies of primary liver cancer.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. Andant C, Puy H, Bogard C et al (2000) Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol 32(6):933–939

    PubMed  Article  CAS  Google Scholar 

  2. Anderson KE, Sassa S, Bishop DF, Desnick RJ (2001) Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. The metabolic and molecular bases of inherited disease. In: Scriver CR, Beaudet AL, Sly WS and Valle D (eds) McGraw-Hill, New York 2: 2991–3062

  3. Andersson C, Bjersing L, Lithner F (1996) The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 240:195–201

    PubMed  Article  CAS  Google Scholar 

  4. Batlle AM (1993) Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B Biol 20:5–22

    Article  CAS  Google Scholar 

  5. Bengtsson NO, Hardell L (1986) Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer 54:115–117

    PubMed  Article  CAS  Google Scholar 

  6. Bjersing L, Andersson C, Lithner F (1996) Hepatocellular carcinoma in patients from Northern Sweden with acute intermittent porphyria: morphology and mutations. Cancer Epidemiol Biomarkers Prev 5:393–397

    PubMed  CAS  Google Scholar 

  7. Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. J Gastroenterol 127(5):S5–S16

    Article  Google Scholar 

  8. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208–1236

    PubMed  Article  Google Scholar 

  9. Deybach JC, Puy H (2011) Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa. J Intern Med 269(5):521–524

    PubMed  Article  CAS  Google Scholar 

  10. Floderus Y, Shoolingin-Jordan P, Harper P (2002) Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet 62(4):288–297

    PubMed  Article  CAS  Google Scholar 

  11. Hardell L, Bengtsson NO, Jonsson U, Eriksson S, Larsson LG (1984) Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigation. Br J Cancer 50:389–397

    PubMed  Article  CAS  Google Scholar 

  12. Harper P, Wahlin S (2007) Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria. Curr Treat Options Gastroenterol 10(6):444–455

    PubMed  Article  Google Scholar 

  13. Innala E, Andersson C (2011) Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med 269(5):538–545

    PubMed  Article  CAS  Google Scholar 

  14. Kauppinen R, Mustajoki P (1988) Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 57:117–120

    PubMed  Article  CAS  Google Scholar 

  15. Kauppinen R, Mustajoki P (1992) Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 71:1–13

    PubMed  CAS  Google Scholar 

  16. Kauppinen R, von und zu Fraunberg M (2002) Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 48(11):1891–1900

    PubMed  CAS  Google Scholar 

  17. Leong TY, Leong AS (2005) Epidemiology and carcinogenesis of hepatocellular carcinoma. HPB (Oxford) 7(1):5–15

    Article  Google Scholar 

  18. Lindstedt G, Nillroth LW, von Schéele C, Schelin U, Swolin B, Zettergren L (1973) [Late first appearance of porphyria in a patient with primary liver cancer] Sen debut av porfyri hos en patient med primär levercancer. Lakartidningen 70(47):4265–4266

    PubMed  CAS  Google Scholar 

  19. Lithner F, Wetterberg L (1984) Hepatocelluar carcinoma in patients with acute intermittent porphyria. Acta Med Scand 215:271–274

    PubMed  Article  CAS  Google Scholar 

  20. Onuki J, Teixeira PC, Medeiros MH et al (2002) Is 5-aminolevulinic acid involved in the hepatocellular carcinogenesis of acute intermittent porphyria? Cell Mol Biol (Noisy-le-grand) 48(1):17–26

    CAS  Google Scholar 

  21. Ostrowski J, Kostrzewska E, Michalak T, Zawirska B, Medrzejewski W, Gregor A (1983) Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias. Gastroenterology 85:1131–1137

    PubMed  CAS  Google Scholar 

  22. Schneider-Yin X, Van Tuyll van Serooskerken AM, Went P et al (2010) Hepatocellular carcinoma in variegate porphyria: a serious complication. Acta Derm Venereol 90(5):512–515

    PubMed  Article  Google Scholar 

  23. Seth AK, Badminton MN, Mirza D, Russell S, Elias E (2007) Liver transplantation for porphyria: who, when, and how? Liver Transpl 13(9):1219–1227

    PubMed  Article  Google Scholar 

  24. Soonawalla ZF, Orug T, Badminton MN et al (2004) Liver transplantation as a cure for acute intermittent porphyria. Lancet 363(9410):705–706

    PubMed  Article  Google Scholar 

  25. Stojeba N, Meyer C, Jeanpierre C et al (2004) Recovery from a variegate porphyria by a liver transplantation. Liver Transpl 10(7):935–938

    PubMed  Article  Google Scholar 

  26. Thunell S, Andersson C, Carlmark B et al (1995) Markers for vulnerability in acute porphyria. A hypothesis paper. Eur J Clin Chem Clin Biochem 33:179–194

    PubMed  CAS  Google Scholar 

  27. Thunell S, Floderus Y, Henrichson A, Harper P (2006) Porphyria in Sweden. Physiol Res 55(Suppl 2):S109–S118

    PubMed  CAS  Google Scholar 

  28. Wahlin S, Harper P, Sardh E, Andersson C, Andersson DE, Ericzon BG (2010) Combined liver and kidney transplantation in acute intermittent porphyria. Transpl Int 23(6):e18–e21

    PubMed  Article  Google Scholar 

  29. Wiman Å (2003) Genetic Characterization of Swedish Families with Hereditary Coproporphyria, Variegate Porphyria, and Erythropoietic Protoporphyria. Dep Med Lab Sci and Tech, Div Clin Chem, Karolinska Institutet, Huddinge Univ Hospital. Stockholm, Karolinska Institutet

Download references

Conflict of interest


Author information



Corresponding author

Correspondence to Eliane Sardh.

Additional information

DEH Andersson, P Harper: Shared senior authorship

Communicated by: Robert J. Desnick

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sardh, E., Wahlin, S., Björnstedt, M. et al. High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria. J Inherit Metab Dis 36, 1063–1071 (2013).

Download citation


  • Porphyria
  • Primary Liver Cancer
  • Acute Intermittent Porphyria
  • Acute Intermittent Porphyria
  • Surveillance Group